Results 81 to 90 of about 302 (133)

Affective Response Categories-Toward Personalized Reactions in Affect-Adaptive Tutoring Systems. [PDF]

Front Artif Intell, 2022
Schmitz-Hübsch A, Stasch SM, Becker R, Fuchs S, Wirzberger M.   +4 more
europepmc   +1 more source

Cones of Noether-Lefschetz divisors and moduli spaces of hyperkähler manifolds. [PDF]

Math Ann
Barros I, Beri P, Flapan L, Williams B.
europepmc   +1 more source

Mathematical modeling of allelopathic stimulatory phytoplankton species using fractal-fractional derivatives. [PDF]

Sci Rep
Kumawat S, Bhatter S, Bhatia B, Purohit SD, Suthar DL.   +4 more
europepmc   +1 more source

A robust natural language text-to-SQL generation framework with dynamic strategies based on LLMs. [PDF]

Sci Rep
Su X, Gu Y, Wang P, Gu W, Qi L, He J.
europepmc   +1 more source

AI-enabled multi-omics integration in colorectal cancer: from molecular stratification to clinical translation. [PDF]

Front Cell Dev Biol
Su H, Wang T, Chen C.
europepmc   +1 more source

Gradient projection method with a new step size for the split feasibility problem. [PDF]

J Inequal Appl, 2018
Tianchai P.
europepmc   +1 more source

Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses. [PDF]

J Transl Med, 2021
Li Y, Lu S, Wang S, Peng X, Lang J.
europepmc   +1 more source

Global Results for Weakly Dispersive KP-II Equations on the Cylinder. [PDF]

Arch Ration Mech Anal
Herr S, Schippa R, Tzvetkov N.
europepmc   +1 more source

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. [PDF]

Nat Commun, 2023
Fuchs S, Danßmann C, Klironomos F, Winkler A, Fallmann J, Kruetzfeldt LM, Szymansky A, Naderi J, Bernhart SH, Grunewald L, Helmsauer K, Rodriguez-Fos E, Kirchner M, Mertins P, Astrahantseff K, Suenkel C, Toedling J, Meggetto F, Remke M, Stadler PF, Hundsdoerfer P, Deubzer HE, Künkele A, Lang P, Fuchs J, Henssen AG, Eggert A, Rajewsky N, Hertwig F, Schulte JH.   +29 more
europepmc   +1 more source

Protocol for cyclic DNA-damaging treatments to generate high mutational burden in the human A549 cell line. [PDF]

STAR Protoc
Imre G, Juhász S.
europepmc   +1 more source